主要文件

查看所有文档

145726

DL-酪氨酸

Name: <SC>DL</SC>-酪氨酸
Brand: ALDRICH

99%

别名:

(±)-2-氨基-3-(4-羟基苯基)丙酸, 3-(4-羟基苯基)-DL-丙氨酸

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:

4-(HO)C₆H₄CH₂CH(NH₂)COOH

化学文摘社编号:

556-03-6

分子量:

181.19

UNSPSC Code:

12352209

NACRES:

NA.22

PubChem Substance ID:

24848742

EC Number:

209-113-1

Beilstein/REAXYS Number:

515881

MDL number:

MFCD00063074

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

Quality Level

100

assay

99%

form

powder

reaction suitability

reaction type: solution phase peptide synthesis

mp

≥300 °C (lit.)

application(s)

peptide synthesis

SMILES string

NC(Cc1ccc(O)cc1)C(O)=O

InChI

1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)

InChI key

OUYCCCASQSFEME-UHFFFAOYSA-N

说明

存储类别

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.

Shannon L Maude et al.

Blood, 125(11), 1759-1767 (2015-02-04)

Early T-cell precursor (ETP) acute lymphoblastic leukemia (ALL) is a recently described subtype of T-ALL characterized by a unique immunophenotype and genomic profile, as well as a high rate of induction failure. Frequent mutations in cytokine receptor and Janus kinase

Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.

W D Phillips et al.

Experimental neurology, 270, 29-40 (2014-12-30)

Muscle-specific tyrosine kinase (MuSK) autoantibodies are the hallmark of a form of myasthenia gravis (MG) that can challenge the neurologist and the experimentalist. The clinical disease can be difficult to treat effectively. MuSK autoantibodies affect the neuromuscular junction in several

F604S exchange in FIP1L1-PDGFRA enhances FIP1L1-PDGFRA protein stability via SHP-2 and SRC: a novel mode of kinase inhibitor resistance.

S P Gorantla et al.

Leukemia, 29(8), 1763-1770 (2015-03-13)

FIP1L1-PDGFRA is a constitutively activated kinase described in chronic eosinophilic leukemia (CEL) and hypereosinophilic syndrome (HES). Imatinib is clinically active in FIP1L1-PDGFRA-positive diseases. Using in vitro screening to identify imatinib-resistant mutations, we frequently detected a Phe to Ser exchange at

查看所有相关文献

全球贸易项目编号

货号	GTIN
145726-100G	04061833544549
145726-25G	04061838736352